ImpediMed（IPD.AX）股价一度飙升高达19%，触及0.044澳元，创下自3月下旬以来的新高点，展现出强劲的反弹势头。这一涨幅标志着自4月28日以来最大的日内百分比上涨，突显了市场对该股的乐观情绪。作为一家医疗技术公司，ImpediMed公布第四季度总合同价值达630万澳元，环比增长29%，显示出业务扩张的积极信号。交易量激增，成交约860万股，远超30日平均的240万股，成为6月11日以来最活跃的交易日。截至最新数据，该股上涨10.8%，将年初至今的亏损缩减至21.2%，为投资者带来一丝喘息之机。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.